Back to all papers

Neuroimaging-derived brain endophenotypes link molecular mechanisms to Alzheimer's disease and aging

December 23, 2025medrxiv logopreprint

Authors

Li, R.,Feng, R.,Liu, A.,Cao, X.,De Jager, P. L.,Bennett, D. A.,The Alzheimer's Disease Functional Genomics Consortium,,Davatzikos, C.,Wen, J.,Wang, G.

Affiliations (1)

  • The Gertrude H. Sergievsky Center, Columbia University

Abstract

Alzheimers disease (AD) genome-wide association studies (GWAS), typically based on clinical phenotypes, have identified numerous risk loci, yet linking these variants to brain changes and molecular processes remains challenging. We developed a DNE-xQTL framework integrating deep learning-derived dimensional neuroimaging endophenotypes (DNEs) with comprehensive brain molecular quantitative trait loci (xQTL) to dissect genetic pathways underlying AD- and aging-related brain variation. By performing GWAS on seven DNEs and applying integrative computational analyses, we biologically annotated each DNE and prioritized xQTL-supported gene targets. This approach both enhanced interpretation of established AD loci through DNE-mediated annotations and revealed underexplored regulatory pathways, organizing 209 candidate genes into evidence-based tiers. We highlight three regulatory clusters: glutamate-receptor and mitochondrial pathways implicating excitatory-neuron vulnerability, SREBP2-associated cholesterol homeostasis linked to vascular dysfunction, and primary-cilia-associated transport implicated in aging. By connecting pre-symptomatic brain alterations to molecular targets and relevant cell types, this framework may inform earlier risk stratification before clinical neurodegeneration occurs.

Topics

genetic and genomic medicine

Ready to Sharpen Your Edge?

Subscribe to join 8,400+ peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.